Clinical Trial Update: ATTR-CM: A Multi-country, Non-interventional Disease Registry

View source ↗

Summary

Pfizer is conducting a multi-country, non-interventional registry for transthyretin amyloid cardiomyopathy (ATTR-CM); the study is currently active but not recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transthyretin Amyloid Cardiomyopathy

Snippet

Sponsor: Pfizer | Conditions: Transthyretin Amyloid Cardiopathy | Status: ACTIVE_NOT_RECRUITING